[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"percutaneous-nephrolithotomy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:percutaneous-nephrolithotomy":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,6,0,[8,50,78,106,131,150],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":49},"100608615","the-effectiveness-of-quadro-liac-plane-block-in-percutaneous-nephrolithotomies-100608615",false,"NCT07203859","The Effectiveness of Quadro İliac Plane Block in Percutaneous Nephrolithotomies","Comparison of the Effects of Ultrasound-Guided Quadro-İliac Plane Block on Postoperative Pain Level and Analgesia Requirement in Patients Undergoing Percutaneous Nephrolithotomy","Inclusion Criteria:\n\n* Adult patients over 18 years of age who underwent percutaneous nephrolithotomy under general anesthesia and were I-II-III according to the American Society of Anesthesiologists (ASA) risk classification were included in the study.\n\nExclusion Criteria:\n\n* patients who did not give consent,\n* patients with coagulopathy,\n* patients with signs of infection at the block application site,\n* patients using anticoagulants,\n* patients with known allergies to any of the study drugs,\n* patients with unstable hemodynamics,\n* patients who could not cooperate during postoperative pain assessment\n* patients who wanted to withdraw from the study,\n* patients with alcohol and drug addiction,\n* patients with musculoskeletal abnormalities","ALL","18 Years","65 Years",{"count":20,"type":21},60,"ESTIMATED","INTERVENTIONAL",[24],"NA","Our aim was to investigate the effect of quadro iliac plane block on postoperative analgesia in patients undergoing percutaneous nephrolithotomy surgery and to determine which areas of the skin this block anesthetizes.",[27,28],"Postoperative Pain","Percutaneous Nephrolithotomy",[30,31,32,33,34,35,36],"postoperative pain","regional anesthesia","percutaneous nephrolithotomy","quadroiliac plane block","opioid free analgesia","ibuprofen","novel fascial plane block","RECRUITING","2026-06-02",{"date":40,"type":41},"2026-06-03","ACTUAL",{"date":43,"type":41},"2025-09-25",{"date":45,"type":21},"2026-10",{"name":47,"class":48},"Cumhuriyet University","OTHER",1,{"id":51,"slug":52,"hasResults":11,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":4,"eligibilityCriteria":56,"healthyVolunteers":57,"sex":16,"minAge":58,"maxAge":59,"enrollmentInfo":60,"targetDuration":4,"studyType":22,"phases":62,"briefSummary":63,"conditions":64,"keywords":4,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":49},"100620904","inhalational-agents-versus-dexmedetomidine-for-maintenance-of-general-anesthesia-100620904","NCT07363681","Inhalational Agents Versus Dexmedetomidine for Maintenance of General Anesthesia","Beyond Inhalational Agents: Dexmedetomidine for Maintenance of General Anesthesia - A Prospective Randomized Clinical Trial","Inclusion Criteria\n\n* Age ≥ 39 years\n* Classified as ASA physical status II-IV\n* Scheduled for elective endoscopic urological surgery (e.g., URS, TUR-B, PCNL, TUR-P)\n* Scheduled for postoperative follow-up in the Post-Anesthesia Care Unit (PACU)\n* Ability to provide written informed consent\n\nExclusion Criteria\n\n* Requirement for conversion to open surgery during the perioperative period\n* Patients who decline to participate in the study\n* Presence of neuropsychiatric disorders (e.g., dementia, Parkinson's disease, epilepsy, or history of head trauma)\n* History of alcohol or substance abuse\n* Use of psychoactive medications\n* Inability to communicate adequately for any reason",true,"39 Years","99 Years",{"count":61,"type":21},150,[24],"The climate crisis and environmental pollution are escalating day by day, making the reduction of carbon footprints increasingly important both on an individual and industrial level. Inhalational anesthetic agents are widely used in daily anesthesia practice. However, some of these agents are released into the environment either unchanged or as metabolic by-products. It can take hundreds of years for these substances to be fully eliminated from nature. Therefore, there is a growing interest in identifying alternative anesthetic agents that are fully metabolized, do not produce waste, have a shorter duration of action, and pose less harm to ecosystems.\n\nRecent clinical studies have shown that dexmedetomidine, when administered intraoperatively via infusion without a loading dose and in combination with inhalational agents, provides more stable hemodynamics and results in a shorter postoperative recovery period. Commonly used as a long-term sedative agent in intensive care units, dexmedetomidine has gained popularity in the intraoperative setting due to its stable hemodynamic profile, low incidence of withdrawal symptoms, and faster recovery.\n\nIn this study, it is aimed to demonstrate the potential use of dexmedetomidine-whose pharmacodynamic and pharmacokinetic properties are well-known to experienced anesthesiologists-as an alternative to inhalational anesthetic agents for the maintenance of anesthesia, particularly in the geriatric patient population.",[65,66,28,67],"Ureterorenoscopic Lithotripsy","Transurethral Resection of the Bladder","Transurethral Resection of the Prostate","2026-01-15",{"date":70,"type":41},"2026-01-23",{"date":72,"type":41},"2024-10-01",{"date":74,"type":21},"2026-03-09",{"name":76,"class":77},"Bakirkoy Dr. Sadi Konuk Research and Training Hospital","OTHER_GOV",{"id":79,"slug":80,"hasResults":11,"nctId":81,"briefTitle":82,"officialTitle":83,"acronym":4,"eligibilityCriteria":84,"healthyVolunteers":11,"sex":16,"minAge":85,"maxAge":18,"enrollmentInfo":86,"targetDuration":4,"studyType":22,"phases":88,"briefSummary":89,"conditions":90,"keywords":93,"overallStatus":96,"whyStopped":4,"lastUpdateSubmitDate":97,"lastUpdatePostDateStruct":98,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":49},"100601727","comparative-study-between-spinal-anesthesia-versus-general-anesthesia-in-supine-percutaneous-nephrolithotomy-operation-100601727","NCT07114250","Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation","Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Patients Undergoing Supine Percutaneous Nephrolithotomy","Inclusion Criteria:\n\n* Age more than 21 years old.\n* Both sexes.\n* American Society of Anesthesiologists physical status (I- II).\n* Patient with single renal stone size 2-3cm prepared for supine Percutaneous nephrolithotomy\n\nExclusion Criteria:\n\n* Patient refusal.\n* Pregnancy\n* Morbid obese with Body mass index \\> 35 kg\u002Fm2.\n* Contraindication for spinal anesthesia.\n* Renal anomalies (horseshoe kidney, ectopic kidney).\n* Presence of multiple stones or staghorn stones.","22 Years",{"count":87,"type":21},70,[24],"The aim of this study is to evaluate the efficacy of spinal anesthesia as an alternative to general anesthesia in PCNL operation in supine position.",[91,28,92],"Spinal Anesthesia","General Anesthesia",[92,94,91,95],"Percutaneous nephrolithotomy","Nephrolithiasis","NOT_YET_RECRUITING","2025-08-04",{"date":99,"type":41},"2025-08-11",{"date":101,"type":21},"2026-05-30",{"date":103,"type":21},"2026-12-30",{"name":105,"class":48},"Tanta University",{"id":107,"slug":108,"hasResults":11,"nctId":109,"briefTitle":110,"officialTitle":111,"acronym":4,"eligibilityCriteria":112,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":113,"targetDuration":4,"studyType":22,"phases":115,"briefSummary":116,"conditions":117,"keywords":118,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":122,"lastUpdatePostDateStruct":123,"startDateStruct":125,"completionDateStruct":127,"leadSponsor":129,"locationsCount":49},"100546294","gram-stain-of-the-first-urine-after-puncture-in-percutaneous-nephrolithotomy-100546294","NCT06393062","Gram Stain of the First Urine After Puncture in Percutaneous Nephrolithotomy","Gram Stain of the First Urine After Intraoperative Renal Puncture in Predicting the Systemic Inflammatory Response After Percutaneous Nephrolithotomy: A Prospective, Randomized Controlled Study","Inclusion Criteria:\n\n* patients with an indication for percutaneous nephrolithotomy due to kidney stone disease.\n\nExclusion Criteria:\n\n* under 18 years old,\n* having an active urinary tract infection before surgery and positive urine cultures,\n* Patients with bilateral kidney stones,\n* DJ stent or nephrostomy placement,\n* Solitary kidney stones,\n* Bleeding disorders,\n* impaired kidney function,\n* a history of antibiotic use for any reason within 2 weeks before randomization were excluded from the study.",{"count":114,"type":21},245,[24],"In this study, investigators compared the systemic inflammatory responses after percutaneous nephrolithotomy (PCNL) patients who were given an expanded empirical antibiotic regimen based on the prediction of the possibility of bacteria identified by Gram staining the first urine after renal puncture and patients whose antibiotic regimen was not performed and whose antibiotic regimen was adjusted according to patient symptoms and culture results. Investigators aimed to test its diagnostic value in predicting and preventing complications.",[28],[119,120,32,121],"fever","gram stain","Systemic inflammatory response syndrome (SIRS)","2025-01-20",{"date":124,"type":41},"2025-01-22",{"date":126,"type":41},"2022-12-01",{"date":128,"type":21},"2025-09-30",{"name":130,"class":48},"Adiyaman University",{"id":132,"slug":133,"hasResults":11,"nctId":134,"briefTitle":135,"officialTitle":136,"acronym":4,"eligibilityCriteria":137,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":138,"targetDuration":4,"studyType":22,"phases":140,"briefSummary":141,"conditions":142,"keywords":4,"overallStatus":96,"whyStopped":4,"lastUpdateSubmitDate":143,"lastUpdatePostDateStruct":144,"startDateStruct":145,"completionDateStruct":146,"leadSponsor":148,"locationsCount":49},"100576304","the-analgesia-effect-of-electroacupuncture-battlefield-acupuncture-versus-sham-electroakupuncture-post-surgery-100576304","NCT06783556","The Analgesia Effect of Electroacupuncture Battlefield Acupuncture Versus Sham Electroakupuncture Post Surgery","The Analgesia Effect of Electroacupuncture of Battlefield Acupuncture (BFA) Versus Sham Electroacupuncture on Pain, Analgesic Dose Reduction and Quality of Life Post Percutaneous Nephrolithotomy Surgery","Inclusion Criteria:\n\n* Men or women aged 18-65 years\n* Patients who have been diagnosed with kidney stones measuring \\> 2 cm and will undergo PCNL surgery\n* VAS score \\\u003C7, assessed 2 hours before PCNL surgery\n* Receive standard analgesic therapy\n* Willing to participate in this study until completion and sign an informed consent.\n\nExclusion Criteria:\n\n* Kidney anatomical abnormalities\n* Ear deformities (microtia)\n* Patients with cognitive impairment, uncooperative (receiving antidepressants or strong opioid or narcotic analgesics)\n* Tumors, wounds or skin infections in the needling area.\n* Heart rhythm disorder, unstable hemodynamics that require intensive care including extremely high body temperature and using a pacemaker.\n* Allergy to acupuncture needles or certain metals\n* Patients who have had a DJ stent or nephrostomy before PCNL\n* History of metal implants in the body except amalgam",{"count":139,"type":21},30,[24],"The goal of this clinical trial is to learn the effect of ear electroacupuncture BFA therapy in reducing pain, analgesic dose, and improving patient quality of live post percutaneous nephrolithotomy surgery. The main questions it aims to answer are:\n\n* Does BFA ear electroacupuncture reduce postoperative pain of percutaneous nephrolithotomy surgery better than sham electroacupuncture group?\n* Does BFA ear electroacupuncture reduce postoperative analgesic dose of percutaneous nephrolithotomy surgery better than sham electroacupuncture group?\n* Does BFA ear electroacupuncture improve postoperative quality of life of percutaneous nephrolithotomy surgery better than sham electroacupuncture group?\n\nResearchers will compare ear electroacupuncture BFA to sham electroacupuncture to see the different analgesia effect between these groups.\n\nParticipants will:\n\n* Get ear electroacupuncture BFA or sham electroacupuncture therapy, 2 hours before surgery for 30 minutes\n* Take drug paracetamol 1000 mg intravenous after surgery according to the needs of the patient's pain complaints after surgery in both groups",[28],"2025-01-18",{"date":124,"type":41},{"date":122,"type":21},{"date":147,"type":21},"2025-06-01",{"name":149,"class":48},"Indonesia University",{"id":151,"slug":152,"hasResults":11,"nctId":153,"briefTitle":154,"officialTitle":155,"acronym":4,"eligibilityCriteria":156,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":157,"enrollmentInfo":158,"targetDuration":4,"studyType":22,"phases":160,"briefSummary":161,"conditions":162,"keywords":164,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":169,"lastUpdatePostDateStruct":170,"startDateStruct":172,"completionDateStruct":174,"leadSponsor":176,"locationsCount":49},"100483398","tubeless-percutaneous-nephrolithotomy-without-reverse-insertion-of-a-ureteral-catheter-100483398","NCT05574517","Tubeless Percutaneous Nephrolithotomy Without Reverse Insertion of a Ureteral Catheter","A Comparative Study of Tubeless Percutaneous Nephrolithotomy With or Without Reverse Ureteral Catheter Insertion","Inclusion Criteria:\n\n* Participants who met the the applications of PCNL surgery in the 2019 Chinese Guidelines for the Diagnosis and Treatment of Urological Diseases\n* Participants who agree to undergo tubeless PCNL\n* The participants' maximum diameter of the stone should be less than 3.5cm\n\nExclusion Criteria:\n\n* Confirmation by computerized tomography (CT) images and blood biochemical indicators of infectious stones or complex staghorn stones\n* Obvious surgical contraindications, such as severe heart and lung insufficiency, abnormal coagulatory function\n* Previous PCNL or nephrolithotomy, presence of an indwelling ureteral stent or nephrostomy tube before surgery\n* Renal trauma or congenital malformation of the urinary system","80 Years",{"count":159,"type":21},200,[24],"Percutaneous nephrolithotomy(PCNL) is a surgical method for upper urinary calculi. The advent of tubeless PCNL (without indwelling nephrostomy tube) has been proved to be safe and effective in reducing postoperative discomfort, shortening hospitalization time and reducing hospitalization costs. Traditional tubeless PCNL usually involves retrograde insertion of the ureteral catheter, which may cause many ureteral related surgical complications. However, there are few reports on tubeless PCNL without reverse ureteral catheter insertion. The goal of this study is to explore the safety and effectiveness of the tubeless PCNL without reverse ureteral catheter insertion.",[163,28],"Urinary Calculi",[165,166,94,167,168],"Ureteral catheter","Without reverse insertion","Tubeless","Urinary calculi","2024-09-23",{"date":171,"type":41},"2024-09-24",{"date":173,"type":41},"2022-10-07",{"date":175,"type":21},"2024-12-31",{"name":177,"class":48},"The First Affiliated Hospital of University of South China"]